Drawing for UROSTRIP

USPTO serial 79325458

UROSTRIP

Reviewed by CopyMark Law Group

Reg. 6891481Status 700Registered
Filing date
Status date
Registration date
Nov 8, 2022
Examiner
RIEPEL, CHRISTINA MAXINE
Law office
TMO LAW OFFICE 124

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with UROSTRIP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dennis S. Prahl

Dennis S. Prahl Ladas & Parry LLP1040 Avenue Of The AmericasNew York, NY 10018

Goods and services

ClassDescriptionStatusFirst use
005*Test strips for medical use for urine analyses*ACTIVE—
009Downloadable software applications for collecting, analyzing and transmitting medical data in the field of urology; downloadable application for mobile phones and for tablet computers for collecting, analyzing and transmitting medical data; downloadable software applications for collecting, analyzing and controlling urological data; computer chips; electronic chips being microchips; encoded electronic chip cards containing programming to enable the collection and analysis of medical data in the field of urologyACTIVE—
010Urological apparatus and instruments, namely, medical devices for diagnosing and treating urological disorders; urine bags, namely, medical collection bags for testing purposes; urine bags being medical collection bags for urine testing purposes equipped with an integrated electronic chip incorporating a diagnostic test strip for analyzing and transmitting data to a server; medical test kit for collecting, analyzing and transmitting medical data relating to urine; medical test kit comprised primarily of a medical diagnostic urine testing apparatus with an integrated computer chip for collecting, analyzing and transmitting medical data relating to urine [ ; test strips for medical use for urine analyses ]ACTIVE—
038Electronic data transmission; data transmission by electronic chips to a server in the field of urologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 21, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 14, 2023INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jul 16, 2023INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 29, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 8, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 8, 2023FIMPFINAL DISPOSITION PROCESSED—
Feb 8, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 20, 2022NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
Nov 16, 2022CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Nov 16, 2022COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Nov 11, 2022PLGLASSIGNED TO PARALEGAL—
Nov 8, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 8, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2022GPNXNOTIFICATION PROCESSED BY IB—
Aug 23, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 3, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 3, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 3, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 19, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 19, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 18, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 18, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2022RINXUSPTO CORRECTION PROCESSED BY IB—
Jul 10, 2022CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Apr 4, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 1, 2022CRSNCORRECTION SENT TO IB—
Mar 30, 2022CRCRCORRECTION CREATED FOR IB—
Mar 17, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 17, 2022RFRRREFUSAL PROCESSED BY MPU—
Feb 18, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Feb 17, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 16, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 7, 2022DOCKASSIGNED TO EXAMINER—
Nov 19, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 11, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance